Pål Hasvold

Pål Hasvold works in General Cardiology affiliated with AstraZeneca (Sweden).

Pål Hasvold is the Medical Evidence Director at AstraZeneca Nordic-Baltic in Sweden. He leads a team responsible for real-world evidence studies in the Nordics, focusing on cardiovascular diseases. He holds a PhD in Pharmacoepidemiology from the University of Oslo and has authored over 30 publications in peer-reviewed journals.